FDA Approves Start of Trial for Cobra PzF™ Stent

A clinical trial for a novel concept coronary stent will soon start enrolling patients in the United States: the COBRA PzF™ coronary stent system was given an investigative device exemption (IDE) by the FDA last month and will shortly begin recruiting at 14 U.S. hospitals; 13 outside U.S. sites have already started the process.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news